Skip Navigation

Disparities in REsults of Immune Checkpoint Inhibitor Treatment DiRECT: A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 Immunotherapy in a Community Oncology Setting

Brief Summary

Type:
Multiple Sites (Solid Tumors)

Study Type:
Supportive Care

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT05364086

Study #:
STUDY00150728

Start Date:
Oct 29, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05364086

View Complete Trial Details & Eligibility at ClinicalTrials.gov